Skip to main content
. 2014 May 26;4:122. doi: 10.3389/fonc.2014.00122

Table 4.

Percent of flare patients utilized medications for urinary symptom relief at baseline and following SBRT for prostate cancer.

Start 1 3 6 9 12 18 24
α1A Inhibitor (%) 31.03 77.78 35.71 34.62 42.86 71.43 85.19 46.15
Anti-inflammatory (%) 0.00 7.41 3.57 3.85 14.29 17.86 3.70 0.00
Urethral analgesics (%) 0.00 0.00 0.00 0.00 3.57 3.57 3.70 0.00